Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek Hart

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Immunological Methods|February 16, 2010
A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodiesMartina L Jones, Therese Seldon, Matthew Smede, et al.
Leukemia & Lymphoma|March 15, 2014
Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myelomaJames Favaloro, Tulita Liyadipitiya, Ross Brown, et al.
Plos One|August 21, 2012
Induction of multi-functional T cells in a phase I clinical trial of dendritic cell immunotherapy in hepatitis C virus infected individualsShuo Li, Stuart Roberts, Magdalena Plebanski, et al.
Journal of Hepatology|July 30, 2010
A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individualsEric J Gowans, Stuart Roberts, Kathryn Jones, et al.
Blood|July 16, 2005
CD molecules 2005: human cell differentiation moleculesHeddy Zola, Bernadette Swart, Ian Nicholson, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Immunological Methods|February 16, 2010
A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodiesMartina L Jones, Therese Seldon, Matthew Smede, et al.
Leukemia & Lymphoma|March 15, 2014
Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myelomaJames Favaloro, Tulita Liyadipitiya, Ross Brown, et al.
Plos One|August 21, 2012
Induction of multi-functional T cells in a phase I clinical trial of dendritic cell immunotherapy in hepatitis C virus infected individualsShuo Li, Stuart Roberts, Magdalena Plebanski, et al.
Journal of Hepatology|July 30, 2010
A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individualsEric J Gowans, Stuart Roberts, Kathryn Jones, et al.
Blood|July 16, 2005
CD molecules 2005: human cell differentiation moleculesHeddy Zola, Bernadette Swart, Ian Nicholson, et al.
Pageof 2